232 related articles for article (PubMed ID: 21514229)
1. Changes in cell-mediated immune response after lung resection surgery for MDR-TB patients.
Park SK; Hong S; Eum SY; Lee IH; Shin DO; Cho JE; Cho S; Cho SN
Tuberculosis (Edinb); 2011 Jul; 91(4):300-7. PubMed ID: 21514229
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis.
Kang MW; Kim HK; Choi YS; Kim K; Shim YM; Koh WJ; Kim J
Ann Thorac Surg; 2010 May; 89(5):1597-602. PubMed ID: 20417785
[TBL] [Abstract][Full Text] [Related]
5. [The changes and the significance of cellular immune function in peripheral blood of patients with multidrug-resistant and extensively drug-resistant pulmonary tuberculosis].
Yang Y; Tang SJ; Zhang Q; Sun H; Liu YD; Hao XH; Yao L; Gu J
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Feb; 34(2):109-13. PubMed ID: 21426728
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immune responses of tuberculosis patients treated with low-dose IL-2 and multidrug therapy.
Johnson BJ; Ress SR; Willcox P; Pati BP; Lorgat F; Stead P; Saha R; Lukey P; Laochumroonvorapong P; Corral L
Cytokines Mol Ther; 1995 Sep; 1(3):185-96. PubMed ID: 9384675
[TBL] [Abstract][Full Text] [Related]
7. Outbreaks of mycobacterium tuberculosis MDR strains induce high IL-17 T-cell response in patients with MDR tuberculosis that is closely associated with high antigen load.
Basile JI; Geffner LJ; Romero MM; Balboa L; Sabio Y García C; Ritacco V; García A; Cuffré M; Abbate E; López B; Barrera L; Ambroggi M; Alemán M; Sasiain MC; de la Barrera SS
J Infect Dis; 2011 Oct; 204(7):1054-64. PubMed ID: 21881121
[TBL] [Abstract][Full Text] [Related]
8. Cellular responses to MPT-51, GlcB and ESAT-6 among MDR-TB and active tuberculosis patients in Brazil.
de Araújo-Filho JA; Vasconcelos AC; Martins de Sousa E; Kipnis A; Ribeiro E; Junqueira-Kipnis AP
Tuberculosis (Edinb); 2008 Sep; 88(5):474-81. PubMed ID: 18676203
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
10. Decreased phosphorylation of STAT-1, STAT-4 and cytokine release in MDR-TB patients with primary resistance.
Kim HJ; Chung DH; Kim MJ; Jang JH; Kim YW; Han SK; Shim YS; Yim JJ
Int J Tuberc Lung Dis; 2008 Sep; 12(9):1071-6. PubMed ID: 18713507
[TBL] [Abstract][Full Text] [Related]
11. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
[TBL] [Abstract][Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
13. The treatment results of patients with multidrug resistant tuberculosis and factors affecting treatment outcome.
Karagöz T; Yazicioğlu Moçin O; Pazarli P; Senol T; Yetiş Duman D; Duman G; Saltürk C; Unal O; Halezeroğlu S
Tuberk Toraks; 2009; 57(4):383-92. PubMed ID: 20037853
[TBL] [Abstract][Full Text] [Related]
14. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
[TBL] [Abstract][Full Text] [Related]
15. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran.
Mirsaeidi SM; Tabarsi P; Khoshnood K; Pooramiri MV; Rowhani-Rahbar A; Mansoori SD; Masjedi H; Zahirifard S; Mohammadi F; Farnia P; Masjedi MR; Velayati AA
Int J Infect Dis; 2005 Nov; 9(6):317-22. PubMed ID: 16183321
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
[TBL] [Abstract][Full Text] [Related]
17. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
[TBL] [Abstract][Full Text] [Related]
18. [Multidrug resistant tuberculosis in Romania in the last years (2004-2007)--an extremely important social phenomenon].
Marica C; Didilescu C; Chiotan D; Galie N; Tănăsescu M; Popescu-Hagen M; Popa M
Pneumologia; 2008; 57(4):195-200. PubMed ID: 19186681
[TBL] [Abstract][Full Text] [Related]
19. [Drug resistant tuberculosis].
Zwolska Z; Augustynowicz-Kopeć E
Pol Merkur Lekarski; 2011 May; 30(179):362-6. PubMed ID: 21675144
[TBL] [Abstract][Full Text] [Related]
20. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.
Yew WW
Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
